MIND MEDICINE MINDMED INC (MNMD)

CA60255C8850 - Common Stock

9.92  +0.42 (+4.42%)

News Image
9 days ago - FinancialNewsMedia

The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

News Image
20 days ago - Numinus Wellness Inc.

Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

News Image
20 days ago - Numinus Wellness Inc.

Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

News Image
21 days ago - Chartmill

Thursday's session: top gainers and losers

Which stocks are moving on Thursday?

News Image
21 days ago - InvestorPlace

Why Is MindMed (MNMD) Stock Up 32% Today?

MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!

News Image
21 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!

News Image
a month ago - InvestorPlace

Why Is ARB IOT (ARBB) Stock Up 230% Today?

ARB IOT stock is taking off on Tuesday after providing investors with a shareholder update and heavy trading of ARBB shares this morning.

News Image
a month ago - InvestorPlace

Why Is MindMed (MNMD) Stock Up 8% Today?

MindMed and other psychedelic stocks are rising today on news of an FDA priority review. Here's what this means for MNMD stock and its peers.

News Image
a month ago - Seeking Alpha

Psychedelic stocks gain after FDA priority review for MDMA therapy (NYSE:CYBN)

The FDA priority review for an MDMA-linked therapy leads to a surge in shares of psychedelic medicine companies such as Mind Medicine (MNMD). Read more here.

News Image
2 months ago - FinancialNewsMedia

How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END